Skip to main content
. 2015 Nov 9;5:62. doi: 10.1186/s13550-015-0142-y

Table 1.

Treatment and imaging for each group

Group Number of mice Treatment Imaging
177Lu-TATE 4 50 MBq 177Lu-TATE i.v. 6 × MRI, 1 × SPECT/CT
TMZ 7 TMZ 50 mg/kg p.o. for 14 days 7 × MRI, 7 × SPECT/CT
Control 3 Saline 3 × MRI

177 Lu-TATE lutetium-177-labelled octreotate, TMZ temozolomide